CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced four new additions to its portfolio of multi-biomarker targeted assays for cancer research, including the Oncomine Immune ...
Thermo Fisher Scientific Inc. TMO recently launched its Applied Biosystems HIV-1 Genotyping Kit with Integrase. This research only evaluates positive human immunodeficiency virus (HIV) samples to ...
Illumina TruSight™ Oncology 500 v2 research assay is now available with built-in HRD biomarker detection, faster turnaround time, and lower tissue sample input Illumina's growing research and clinical ...
Built on Alamar's proprietary NULISA™ platform, the NULISAqpcr BD-pTau217 Assay delivers unprecedented sensitivity and specificity from non-invasive sample types such as plasma, serum and dried blood ...
CARLSBAD, Calif. & PHOENIX--(BUSINESS WIRE)--A new high-throughput, microarray-based assay designed to detect more than 6,000 genomic variations associated with inherited disease now provides ...
Thermo Fisher Scientific introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve SARS-CoV-2 surveillance. The assay is designed to enable early identification of new and known ...
Before Aβ snaps into the rigid amyloid fibrils that predominate in plaques, the peptide clumps into soluble oligomers. Deemed the most toxic form of Aβ, these fledgling aggregates have also been ...
The MarketWatch News Department was not involved in the creation of this content. New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback